Le Lézard
Classified in: Health, Covid-19 virus
Subject: PER

Senior Congressional Health Counsel Stephen Holland Joins Crowell & Moring


Expands Firm's Health Care and FDA Policy and Legislative Capabilities

WASHINGTON, April 9, 2024 /PRNewswire/ -- Stephen Holland, former senior health counsel on the Committee on Energy & Commerce, U.S. House of Representatives, has joined Crowell & Moring, bringing more than a decade of legislative experience on Capitol Hill.

In his role as senior counsel, Holland oversaw health matters for Rep. Frank Pallone, D-N.J., the former chair and current ranking member of the House Energy & Commerce Committee. Prior to his service on the Energy & Commerce Committee, Holland was counsel to Rep. Kurt Schrader of Oregon. Throughout his tenure on Capitol Hill, he focused on improved food, drug, and medical device innovation and regulation at the Food and Drug Administration. 

"Stephen brings instant credibility and gravitas in the health care and FDA arenas," said James G. Flood, co-chair of Crowell & Moring's Government Affairs Group and former counsel to Senate Majority Leader Chuck Schumer, D-N.Y. "He enhances our ability to provide a 360-degree perspective to our clients because he has firsthand knowledge of how health care legislation and policy are made and the levers of Congress work."

As a senior counsel in Crowell's Government Affairs Group, Holland will advise clients on public policy initiatives coming out of Congress and on federal regulations impacting the health care industry, especially in the medical device, vaccine, distributor, and pharmaceutical sectors, including companies seeking FDA approval.

Holland will work closely with Tyler O'Connor, who also served on the House Energy & Commerce Committee as energy counsel, to provide timely insights on actions coming out of the committee. He will also collaborate with members of the Health Care Group and Crowell Health Solutions, the firm's strategic health care consulting firm.

"Health care is one of the key pillars of our government affairs practice and Stephen's time on Capitol Hill, combined with his relationships on both sides of the aisle, will be a great value-add for our clients," said Aaron C. Cummings, co-chair of Crowell's Government Affairs Group and former chief of staff to Senator Chuck Grassley, R-Iowa.

Holland has been involved in most of the major health care issues and legislation in the U.S. Congress during the Trump and Biden administrations, including leading the negotiations and drafting of the Food and Drug Omnibus Reform Act of 2022 and the reauthorization of FDA user fees. During the COVID-19 pandemic, he worked to secure billions of dollars for research, development, distribution, and promotion of vaccines, treatment, and diagnostic tests in the CARES Act, the Fiscal Year 2021 Omnibus, and the American Rescue Plan Act.

"I was drawn to Crowell & Moring because it has a widely-respected, bipartisan government affairs group, as well as a leading health care regulatory practice, to complement the work that I will be doing for clients," Holland said. "With new and ever-changing regulation around drug pricing, artificial intelligence, clinical trials, and supply chain sustainability, I look forward to advising clients on how to navigate the halls of Congress and the executive branch."

About Crowell & Moring LLP
Crowell & Moring is an international law firm with operations in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service as well as its programs and initiatives to advance diversity, equity, and inclusion.

Media Contact:
Email: [email protected]

SOURCE Crowell & Moring LLP


These press releases may also interest you

at 04:00
Forum will be held on May 30 at the Science Museum, LondonChaired by Professor Sir Munir Pirmohamed, Forum to consist of four panel sessions highlighting solutions to pressing issues facing private and public-sector innovators in the healthcare...

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligencetm solution, featuring a new post-approval variations module. The module for post-approval variations...

at 03:00
Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting,...

at 02:58
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million (the "Rights Issue"). The Rights Issue was resolved by the Board of...

at 02:34
SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the...

at 02:14
Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in...



News published on and distributed by: